Cardiovascular Diseases
6 competing products in clinical development for Cardiovascular Diseases.
Pipeline by Phase
Phase 22
Phase 32
Approved2
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Efficacy and safety of combination therapy of moderate-intensity statin and ezetimibe compared to high-intensity statin | Yuhan | Approved | Completed | 43 |
| Prasugrel (Crushed tablets) + Prasugrel (Integral tablets) | Daiichi Sankyo | Approved | Completed | 43 |
| raloxifene + placebo | Eli Lilly | Phase 3 | Completed | 40 |
| polypill + Usual cardiovascular medications | Dr. Reddy's Laboratories | Phase 3 | Completed | 37 |
| Prasugrel (CS-747) + Clopidogrel | Eli Lilly | Phase 2 | Completed | 35 |
| Lexiscan | Astellas Pharma | Phase 2 | Completed | 35 |